Abstract: The present application provides a method, apparatus, device and medium for virtual interaction, wherein the method includes: presenting a media content stream in a virtual space, wherein the media content stream includes at least one interactive object; switching a current camera position to a target camera position according to interactive indication information; presenting an interactive trigger zone and the interactive object in interactive space of the target camera position; and interacting with the interactive object according to the interactive trigger zone. The present application makes interactive operations of the user in the virtual space more vivid and rich, and thus enhances interactivity of the user in the virtual space and improves interactive quality of the virtual interaction.

Abstract: Provided are an epitope peptide (or a variant thereof) that can be used for preventing or treating an EBV infection, a recombinant protein containing the epitope peptide (or variant thereof) and a carrier protein, and the use of the epitope peptide (or variant thereof) and the recombinant protein. Further provided are an antibody against the epitope peptide, and the use thereof in the detection, prevention and/or treatment of an EBV infection and/or diseases caused by the infection.

Abstract: The present invention relates to an ultrathin omnidirectional vibration-isolation metasurface structure and a design method thereof. The omnidirectional vibration-isolation metasurface structure includes a flat plate and a vibration isolation metasurface structure arranged on the flat plate. The vibration isolation metasurface structure is designed in any closed shape according to the shape and position of a vibration source. The vibration isolation metasurface structure is composed of periodically arranged supercells. Each supercell includes j unit cells with a gradient index. The unit cell is in a zigzag shape. The total reflection of elastic waves at any incident angle is realized by designing an elastic wave metasurface with a sub-wavelength thickness in the present invention, so that a vibration isolation purpose is achieved.

Abstract: A method for trapping noble gas atoms and molecules in oxide nanocages that includes providing oxide nanocages on a metallic substrate, ionizing a noble gas to form noble gas cations, applying a voltage to the metallic substrate, contacting the oxide nanocages with the noble gas cations, and deionizing the cations to form noble gas atoms and molecules that are trapped within the oxide nanocages. In one embodiment of the present device, polygonal prism organosilicate cages on a ruthenium thin film can trap noble gases.

Abstract: A method is provided that protects electronic Identity information based on key derived operation. The method includes using an electronic Identity server to send an application derived identifier of the application and user electronic Identity code to a host security module that randomly generates an application master key, encrypts the application derived identifier with the application master key, and gets an application encryption key. The host security module encrypts the user electronic Identity code with the application encryption key, and gets an encryption document. The electronic Identity server codes the encryption document and an application identity code, and gets an application electronic Identity code. The electronic Identity server uses the application electronic Identity code as the user identifier.

Abstract: A method is provided that protects electronic Identity information based on key derived operation. The method includes using an electronic Identity server to send an application derived identifier of the application and user electronic Identity code to a host security module that randomly generates an application master key, encrypts the application derived identifier with the application master key, and gets an application encryption key. The host security module encrypts the user electronic Identity code with the application encryption key, and gets an encryption document. The electronic Identity server codes the encryption document and an application identity code, and gets an application electronic Identity code. The electronic Identity server uses the application electronic Identity code as the user identifier.

Abstract: A method is provided that protects electronic Identity information based on key derived operation. The method includes using an electronic Identity server to send an application derived identifier of the application and user electronic Identity code to a host security module that randomly generates an application master key, encrypts the application derived identifier with the application master key, and gets an application encryption key. The host security module encrypts the user electronic Identity code with the application encryption key, and gets an encryption document. The electronic Identity server codes the encryption document and an application identity code, and gets an application electronic Identity code. The electronic Identity server uses the application electronic Identity code as the user identifier.

Abstract: The present invention relates to a method to protect electronic Identity information based on key derived operation, which comprises: an electronic Identity server sends the application derived identifier of the application and user electronic Identity code to the host security module; an host security module generates randomly an application master key, encrypts the application derived identifier with the application master key, and gets an application encryption key; the host security module encrypts the user electronic Identity code with the application encryption key, and gets an encryption document; the electronic Identity server codes the encryption document and an application identity code, and gets an application electronic Identity code; the electronic Identity server uses the application electronic Identity code as the user identifier.

Abstract: A method for generating and check-controlling a network identity identification code in a network electronic identity is provided for the establishment of a unified network identity management and service ecosystem that effectively protects the network application security and identity information privacy of citizens. A server performs initialization and generates and distributes random numbers while receiving and auditing a request to generate a network identity identification code from a client. If the client passes the audit, encryption coding is performed and a network identity identification code is generated and sent to a network electronic identification card through the client. The network electronic identification card performs check processing of the network identity identification code, and feeds back a result to the server. The server stores the network identity identification code into a database, and informs the user.

Abstract: An implantable or insertable medical device is provided which includes as components: (a) a substrate component comprising a depression that is at least partially filled with a therapeutic agent-containing material that comprises a first therapeutic agent, and (b) a pre-formed filter insert disposed in the depression such that it regulates transport of chemical species between the depression and the exterior of the device upon implantation or insertion of the device in vivo.

Abstract: The present invention relates to a method for generating and check-controlling a network identity identification code in a network electronic identity. The method comprises: a server performing initialization and performing generation and distribution of random numbers; receiving and auditing a request to generate the network identity identification code from a client; if the auditing is passed, performing encryption coding and generating a network identity identification code, and then sending the network identity identification code to a network electronic identification card through the client; the network electronic identification card performing the check processing of a network identity identification code, and feeding back a result to the server; the server storing the network identity identification code into a database, and informing the user.

Abstract: An implantable medical device for releasing therapeutic agent having a medical device body and a plurality of reservoir-defining structures disposed on a surface of the body. A reservoir can be defined by the reservoir-defining structures and therapeutic agent may be located in the reservoir. A cover may extend over the reservoir so that the therapeutic agent is released from the reservoir when the medical device implanted. Methods for making the medical device may also include providing a medical device body, positioning a plurality of reservoir-defining structures on a surface of the body to form a reservoir, loading therapeutic agent into the reservoir, and covering the reservoir so that the therapeutic agent may release when the medical device is implanted. Alternatively, the reservoir may be covered with a cover and an opening formed in the cover so that the therapeutic agent may release when the medical device is implanted.

Abstract: According to an aspect of the present invention, implantable or insertable medical devices are provided which contain (a) one or more depressions that contain at least one therapeutic agent, and (b) a nanoporous coating, disposed over the therapeutic-agent-containing depressions, which regulate transport of species between the therapeutic-agent-containing depressions and the exterior of the device. The implantable or insertable devices are configured to preform a role beyond mere drug delivery, for example, providing mechanical and/or electrical functions within the body, among other functions. An advantage of the present invention is that medical devices may be provided, which release therapeutic agents in quantities far exceeding the void volume within the nanoporous coating, while at the same time providing functionality that extends beyond drug delivery. Such release may further approach or achieve a zero order kinetic drug release profile.

Abstract: According to an aspect of the present invention, implantable or insertable medical devices are provided which contain the following: (a) substrate having one or more depressions that contain at least one therapeutic agent and (b) a porous membrane disposed over the substrate and the one or more depressions, which regulate transport of chemical species between the therapeutic-agent-containing depressions and the exterior of the device. The substrate and the porous membrane are formed of different materials each with a different thermal expansion coefficient. Moreover, one of the substrate and the porous membrane at least partially surrounds the other. Other aspects of the present invention are directed to methods of making such medical devices, and methods of treatment using such medical devices.

Abstract: Described herein are implantable medical devices comprising a biocompatible polymer comprising a triggerable bioadhesive property that allows the device to adhere to body tissue. The triggerable bioadhesive property of the polymer can be triggered or activated by exposure to a stimulus. Also, the present invention pertains to methods of making an implantable medical device comprising a biocompatible polymer comprising a triggerable bioadhesive property that allows the device to adhere to body tissue.

Abstract: An endoprosthesis such as a coronary stent includes a polymeric reservoir of drug and an over coating formed of ceramic or metal for controlling elution of drag from the reservoir.

Abstract: The present invention is directed to implantable medical devices which may be used for controllably releasing a therapeutic agent within a patient and methods for making the same. These medical devices may include porous coatings, which may be polymer-free, located on an outer surface or abluminal surface of the medical device. The medical device may be a stent. The pores of the porous coating may be expandable to facilitate loading of the therapeutic agent. The medical device may be triggerable upon implantation of the medical device such that the volume of the voids shrinks to eject the therapeutic agent. The voids may be slots in the stent. Expandable materials or structures may be positioned in the voids to expand upon implantation and eject the therapeutic agent.

Abstract: According to certain aspects of the invention, implantable or insertable medical devices are provided that contain one or more nanoporous regions, which may further comprise interconnected nanopores. Other aspects of the invention are directed to implantable or insertable medical devices that contain one or more nanostructured regions, which are formed by a variety of methods. Still other aspects of the invention are directed to implantable or insertable medical devices having nanotextured surface regions, in which cell-adhesion-promoting biomolecules (e.g., glycosaminoglycans, proteoglycans, cell adhesion peptides, and adhesive proteins) are provided on, within or beneath the nanotextured surface regions.

Abstract: An endoprosthesis such as a coronary stent includes a luminal surface, at least a portion of which is covered with a first coating including a first drug, and an abluminal surface, at least a portion of which is covered with a second coating including a second drug. The first drug has a first eluting profile based on the first coating, and the second drug has a second eluting profile based on the second coating, the first eluting profile being different from the second eluting profile. Methods of making the same are also provided.

Abstract: According to an aspect of the present invention, implantable or insertable medical devices are provided which contain (a) one or more depressions that contain at least one therapeutic agent, and (b) a nanoporous coating, disposed over the therapeutic-agent-containing depressions, which regulate transport of species between the therapeutic-agent-containing depressions and the exterior of the device. The implantable or insertable devices are configured to preform a role beyond mere drug delivery, for example, providing mechanical and/or electrical functions within the body, among other functions. An advantage of the present invention is that medical devices may be provided, which release therapeutic agents in quantities far exceeding the void volume within the nanoporous coating, while at the same time providing functionality that extends beyond drug delivery. Such release may further approach or achieve a zero order kinetic drug release profile.